Vitamin D biology revealed through the study of knockout and transgenic mouse models

Annual Review of Nutrition

Volumn 33, Issue , 2013, Pages 71-85

  Christakos, Sylvia ^a   Seth, Tanya ^a   Hirsch, Jennifer ^a   Porta, Angela ^a   Moulas, Anargyros ^a   Dhawan, Puneet ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

1,25 dihydroxyvitamin D3; 25 hydroxyvitamin D3 24 hydroxylase (CYP24A1); 25 hydroxyvitamin D3 1 hydroxylase (CYP27B1); Calbindin D9k; Klotho; Transient receptor potential vanilloid type 5 (TRPV5); Transient receptor potential vanilloid type 6 (TRPV6)

Indexed keywords

CALBINDIN; CALCIFEDIOL; CLAUDIN; CLAUDIN 2; CYP 27B1; CYTOCHROME; ESTROGEN RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; UNCLASSIFIED DRUG; VITAMIN D;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; CALCIUM ABSORPTION; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOVASCULAR SYSTEM; ENTERITIS; IMMUNE SYSTEM; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET ORGAN; TRANSGENIC MOUSE; VITAMIN D METABOLISM;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84880656935     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071812-161249     Document Type: Article

References (102)

1. ADHR Consort. 2000. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26:345-48
2. AjibadeD, Benn BS, Christakos S. 2010. Mechanism of action of 1,25-dihydroxyvitamin D3 on intestinal calcium absorption and renal calcium transport. In Vitamin D, ed. MF Holick, pp. 175-87. New York: Humana/Springer
3. Ajibade DV, Dhawan P, Fechner AJ, Meyer MB, Pike JW, Christakos S. 2010. Evidence for a role of prolactin in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal calcium absorption, and the 25-hydroxyvitamin D3 1αhydroxylase gene by prolactin. Endocrinology 151:2974-84
4. Akhter S, Kutuzova GD, Christakos S, DeLuca HF. 2007. Calbindin D9k is not required for 1,25-dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine. Arch. Biochem. Biophys. 460: 227-32
5. al-Aqeel A, Ozand P, Sobki S, Sewairi W, Marx S. 1993. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII). Clin. Endocrinol. (Oxf.) 39:229-37
6. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, et al. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140:4982-87
7. Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, et al. 1986. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J. Clin. Invest. 77:1661-67
8. Benn BS, Ajibade D, Porta A, Dhawan P, Hediger M, et al. 2008. Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 149:3196-205
9. Bianco SD, Peng JB, Takanaga H, Suzuki Y, Crescenzi A, et al. 2007. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J. Bone Miner. Res. 22:274-85
10. Bikle D, Adams J, Christakos S. 2008. Vitamin D: production, metabolism, mechanism of action, and clinical requirements. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, ed. C Rosen, pp. 141-47. Washington, DC: Am. Soc. Bone Miner. Res.
11. Boass A, Toverud SU, Pike JW, Haussler MR. 1981. Calcium metabolism during lactation: enhanced intestinal calcium absorption in vitamin D-deprived, hypocalcemic rats. Endocrinology 109:900-7
12. Bouillon R, Bischoff-Ferrari H, Willett W. 2008. Vitamin D and health: perspectives from mice and man. J. Bone Miner. Res. 23:974-79
13. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, et al. 2008. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29:726-76
14. Bouillon R, Okamura WH, Norman AW. 1995. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 16:200-57
15. Boyan BD, Hurst-Kennedy J, Denison TA, Schwartz Z. 2010. 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1α,25(OH)2D3 in hypertrophic cells. J. Steroid Biochem. Mol. Biol. 121:212-16
16. Brommage R, Baxter DC, Gierke LW. 1990. Vitamin D-independent intestinal calcium and phosphorus absorption during reproduction. Am. J. Physiol. 259:G631-38
17. Bronner F, Pansu D, SteinWD. 1986. An analysis of intestinal calcium transport across the rat intestine. Am. J. Physiol. 250:G561-69
18. Cantorna MT. 2010. Mechanisms underlying the effect of vitamin D on the immune system. Proc. Nutr. Soc. 69:286-89
19. Cantorna MT. 2012. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch. Biochem. Biophys. 523:103-6
20. Cantorna MT, Hayes CE, DeLucaHF. 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:7861-64
21. Cheng CY, Kuro-o M, Razzaque MS. 2011. Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system. Adv. Chronic Kidney Dis. 18:91-97
22. Christakos S. 2008. Vitamin D gene regulation. In Principles of Bone Biology, ed. JP Bilezikian, LG Raisz, T Martin, pp. 779-94. San Diego, CA: Elsevier
23. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. 2010. Vitamin D: metabolism. Endocrinol. Metab. Clin. North Am. 39:243-53
24. Christakos S, DeLuca HF. 2011. Minireview: Vitamin D: Is there a role in extraskeletal health? Endocrinology 152:2930-36
25. CuiM, LiQ, Johnson R, Fleet JC. 2012. Villin promoter-mediated transgenic expression of transient receptor potential cation channel, subfamily V, member 6 (TRPV6) increases intestinal calcium absorption in wild-type and vitamin D receptor knockout mice. J. Bone Miner. Res. 27:2097-107
26. Dardenne O, Prud?homme J, Arabian A, Glorieux FH, St-Arnaud R. 2001. Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142:3135-41
27. Dardenne O, Prud?homme J, Hacking SA, Glorieux FH, St-Arnaud R. 2003. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). Bone 32:332-40
28. Dardenne O, Prud?homme J, Hacking SA, Glorieux FH, St-Arnaud R. 2003. Rescue of the pseudovitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J. Bone Miner. Res. 18:637-43
29. Dhawan P, Hsaio C, Yehia G, Porta A, Lieben L, et al. 2012. Transgenic expression of the vitamin D receptor restricted to the ileum cecum and colon of VDR knockout mice rescues VDR dependent rickets. J. Bone Miner. Res. 27(Suppl. 1):S34
30. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, et al. 2002. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol. Endocrinol. 16:1524-37
31. Favus MJ. 1985. Factors that influence absorption and secretion of calcium in the small intestine and colon. Am. J. Physiol. 248:G147-57
32. Favus MJ, Angeid-Backman E. 1985. Effects of 1,25(OH)2D3 and calcium channel blockers on cecal calcium transport in the rat. Am. J. Physiol. 248:G676-81
33. Favus MJ, Kathpalia SC, Coe FL, Mond AE. 1980. Effects of diet calcium and 1,25-dihydroxyvitamin D3 on colon calcium active transport. Am. J. Physiol. 238:G75-78
34. Fleet JC, Eksir F, Hance KW, Wood RJ. 2002. Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G618-25
35. Fleet JC, Schoch RD. 2011. Molecular mechanisms for regulation of intestinal calcium and phosphate absorption by vitamin D. In Vitamin D, ed. D Feldman, JW Pike, JS Adams, pp. 349-62. New York: Academic
36. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. 2003. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17:2386-92
37. Fujita H, Sugimoto K, Inatomi S, Maeda T, OsanaiM, et al. 2008. Tight junction proteins claudin-2 and-12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol. Biol. Cell 19:1912-21
38. Glorieux FH, St-Arnaud R. 1998. Molecular cloning of (25-OHD)-1α- hydroxylase: an approach to the understanding of vitamin D pseudo-deficiency. Recent Prog. Horm. Res. 53:341-49, discussion 350
39. Goltzman D. 2010. Vitamin D action: lessons learned from genetic mouse models. Ann. N. Y. Acad. Sci. 1192:145-52
40. Halloran BP, DeLuca HF. 1980. Calcium transport in small intestine during early development: role of vitamin D. Am. J. Physiol. 239:G473-79
41. Halloran BP, DeLuca HF. 1980. Calcium transport in small intestine during pregnancy and lactation. Am. J. Physiol. 239:E64-68
42. Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, et al. 2013. Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92:77-98
43. Henry HL, Norman AW. 1978. Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science 201:835-37
44. Hirst MA, Feldman D. 1981. 1,25-Dihydroxyvitamin D3 receptors in mouse colon. J. Steroid Biochem. 14:315-19
45. Hoenderop JG, Dardenne O, Van Abel M, Van Der Kemp AW, Van Os CH, et al. 2002. Modulation of renalCa2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice. FASEB J. 16:1398-406
46. Hoenderop JG, van Leeuwen JP, van der Eerden BC, Kersten FF, van der Kemp AW, et al. 2003. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112:1906-14
47. Holick MF. 2007. Vitamin D deficiency. N. Engl. J. Med. 357:266-81
48. Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, et al. 2007. α-Klotho as a regulator of calcium homeostasis. Science 316:1615-18
49. Jarnagin K, Brommage R, DeLuca HF, Yamada S, Takayama H. 1983. 1-but not 24-hydroxylation of vitamin D is required for growth and reproduction in rats. Am. J. Physiol. 244:E290-97
50. Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, et al. 2011. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 31:3653-69
51. Kovacs CS. 2011. Fetus, neonate and infant. In Vitamin D, ed. D Feldman, JWPike, JS Adams, pp. 625
52. New York: Academic
53. Kovacs CS. 2012. The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies. Annu. Rev. Nutr. 32:97-123
54. Kuro-o M. 2010. Klotho. Pflugers Arch. 459:333-43
55. Kuro-o M. 2010. Overview of the FGF23-Klotho axis. Pediatr. Nephrol. 25:583-90
56. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51
57. Kutuzova GD, DeLuca HF. 2004. Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties. Arch. Biochem. Biophys. 432:152-66
58. Kutuzova GD, Sundersingh F, Vaughan J, Tadi BP, Ansay SE, et al. 2008. TRPV6 is not required for 1α,25-dihydroxyvitamin D3-induced intestinal calcium absorption in vivo. Proc. Natl. Acad. Sci. USA 105:19655-59
59. Lambers TT, Mahieu F, Oancea E, Hoofd L, de Lange F, et al. 2006. Calbindin-D28K dynamically controls TRPV5-mediated Ca2+ transport. EMBO J. 25:2978-88
60. Lemire JM, Archer DC. 1991. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87:1103-7
61. Li YC, AmlingM, Pirro AE, Priemel M, Meuse J, et al. 1998. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391-96
62. Li YC, Pirro AE, Amling M, Delling G, Baron R, et al. 1997. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 94:9831-35
63. Lieben L, Benn BS, Ajibade D, Stockmans I, Moermans K, et al. 2010. Trpv6mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis. Bone 47:301-8
64. Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, et al. 2012. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J. Clin. Invest. 122:1803-15
65. Liu S, Tang W, Zhou J, Stubbs J.R., Luo Q, et al. 2006. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J. Am. Soc. Nephrol. 17:1305-15
66. Masuyama R, Nakaya Y, Katsumata S, Kajita Y, UeharaM, et al. 2003. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption. J. Bone Miner. Res. 18:1217-26
67. Mattner F, Smiroldo S, Galbiati F, MullerM, Di Lucia P, et al. 2000. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur. J. Immunol. 30:498-508
68. Meehan TF, DeLuca HF. 2002. The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch. Biochem. Biophys. 408:200-4
69. Ohnishi M, Nakatani T, Lanske B, Razzaque MS. 2009. Reversal of mineral ion homeostasis and softtissue calcification of klotho knockout mice by deletion of vitaminD1α-hydroxylase. Kidney Int. 75:1166-72
70. PahujaDN, DeLucaHF. 1981. Stimulation of intestinal calcium transport and bone calciummobilization by prolactin in vitamin D-deficient rats. Science 214:1038-39
71. Panda DK, Miao D, Bolivar I, Li J, Huo R, et al. 2004. Inactivation of the 25-hydroxyvitamin D 1α-hydroxylase and vitaminDreceptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J. Biol. Chem. 279:16754-66
72. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, et al. 2001. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 98:7498-503
73. Pansu D, Bellaton C, Bronner F. 1981. Effect of Ca intake on saturable and nonsaturable components of duodenal Ca transport. Am. J. Physiol. 240:G32-37
74. Parfitt AM, Mathews CH, Brommage R, Jarnagin K, DeLucaHF. 1984. Calcitriol but no othermetabolite of vitaminDis essential for normal bone growth and development in the rat. J. Clin. Invest. 73:576-86
75. Petith MM, Wilson HD, Schedl HP. 1979. Vitamin D dependence of in vivo calcium transport and mucosal calcium binding protein in rat large intestine. Gastroenterology 76:99-104
76. Pike JW, Meyer MB. 2010. The vitaminDreceptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol. Metab. Clin. North Am. 39:255-69
77. Plum LA, DeLuca HF. 2010. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 9:941-55
78. Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B. 2006. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20:720-22
79. Renkema KY, Nijenhuis T, van der Eerden BC, van der Kemp AW, Weinans H, et al. 2005. Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice. J. Am. Soc. Nephrol. 16:3188-95
80. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, et al. 1999. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J. Clin. Invest. 103:239-51
81. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, et al. 2011. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 365:410-21
82. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, et al. 2004. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113:561-68
83. Song Y, Kato S, Fleet JC. 2003. Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J. Nutr. 133:374-80
84. Song Y, Peng X, Porta A, Takanaga H, Peng JB, et al. 2003. Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144:3885-94
85. Spach KM, Nashold FE, Dittel BN, Hayes CE. 2006. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 177:6030-37
86. St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, et al. 2000. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141:2658-66
87. Stubbs J.R., Liu S, Tang W, Zhou J, Wang Y, et al. 2007. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J. Am. Soc. Nephrol. 18:2116-24
88. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF. 1979. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206:1188-90
89. TsujikawaH, KurotakiY, FujimoriT, Fukuda K, NabeshimaY. 2003. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17:2393-403
90. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, et al. 2001. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc. Natl. Acad. Sci. USA 98:13324-29
91. Van Cromphaut SJ, Rummens K, Stockmans I, Van Herck E, Dijcks FA, et al. 2003. Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptorindependent mechanisms. J. Bone Miner. Res. 18:1725-36
92. Wang Y, Marling SJ, Zhu JG, Severson KS, DeLuca HF. 2012. Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor. Proc. Natl. Acad. Sci. USA 109:8501-4
93. Wasserman RH. 2004. Vitamin D and the dual processes of intestinal calcium absorption. J. Nutr. 134:3137-39
94. Woudenberg-Vrenken TE, Lameris AL, Weissgerber P, Olausson J, Flockerzi V, et al. 2012. Functional TRPV6 channels are crucial for transepithelial Ca2+ absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 303:G879-85
95. Woudenberg-Vrenken TE, van der Eerden BC, van der Kemp AW, van Leeuwen JP, Bindels RJ, Hoenderop JG. 2012. Characterization of vitamin D-deficient klotho-/-mice: Do increased levels of serum 1,25(OH)2D3 cause disturbed calcium and phosphate homeostasis in klotho-/-mice? Nephrol. Dial. Transplant. 27:4061-68
96. Xiang W, Kong J, Chen S, Cao LP, Qiao G, et al. 2005. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab. 288:E125-32
97. Xue Y, Fleet JC. 2009. Intestinal vitaminDreceptor is required for normal calcium and bonemetabolism in mice. Gastroenterology 136:1317-27, e1-2
98. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, et al. 1997. Mice lacking the vitaminDreceptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16:391-96
99. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. 2008. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149:3656-67
100. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. 2008. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice. Kidney Int. 74:170-79
101. Zinser GM, Suckow M, Welsh J. 2005. Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J. Steroid Biochem. Mol. Biol. 97:153-64
102. Zinser GM, Sundberg JP, Welsh J. 2002. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis 23:2103-9